+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival



DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival



Cellular Physiology and Biochemistry 36(4): 1419-1429



Single nucleotide polymorphisms (SNPs) in the DNA repair genes are suspected to be related to the survival of lung cancer patients due to their possible influence on DNA repair capacity (DRC). However, the study results are inconsistent. A follow-up study of 610 non-small cell lung cancer (NSCLC) patients was conducted to investigate genetic polymorphisms associated with the DNA repair genes in relation to NSCLC survival; 6 SNPs were genotyped, including XRCC1 (rs25487 G>A), hOGG1 (rs1052133 C>G), MUTYH (rs3219489 G>C), XPA (rs1800975 G>A), ERCC2 (rs1799793 G>A) and XRCC3 (rs861539 C>T). Kaplan- Meier survival curve and Cox proportional hazards regression analyses were performed. SNP-SNP interaction was also examined using the survival tree analysis. Advanced disease stage and older age at diagnosis were associated with poor prognosis of NSCLC. Patients with the variant 'G' allele of hOGG1 rs1052133 had poor overall survival compared with those with the homozygous wild 'CC' genotype, especially in female patients, adenocarcinoma histology, early stage, light smokers and without family history of cancer. For never smoking female lung cancer patients, individuals carrying homozygous variant 'AA' genotype of XPA had shorter survival time compared to those with wild 'G' alleles. Furthermore, females carrying homozygous variant XPA and hOGG1 genotypes simultaneously had 2.78-fold increased risk for death. Among all 6 polymorphisms, the homozygous variant 'AA' of XPA carriers had poor prognosis compared to the carriers of wild 'G' alleles of XPA together with other base excision repair (BER) polymorphisms. Besides disease stage and age, the study found DNA repair gene polymorphisms were associated with lung cancer survival.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057554899

Download citation: RISBibTeXText

PMID: 26159902

DOI: 10.1159/000430307


Related references

Polymorphisms in the DNA repair gene XRCC1 and survival of non-small cell lung cancer. Journal of Clinical Oncology 23(16_Suppl): 9585-9585, 2016

An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Molecular Biology Reports 38(8): 5231-5241, 2011

Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer. Cancer Science 101(11): 2436-2442, 2010

Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer. Plos one 9(6): E99843, 2014

Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium. Clinical Cancer Research 23(24): 7550-7557, 2017

Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis. Molecular Carcinogenesis 51(7): 546-552, 2012

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Annals of Oncology 17(4): 668-675, 2006

Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer. Journal of Thoracic Oncology 6(1): 183-189, 2011

Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer. Pathology Research and Practice 214(1): 44-52, 2018

Polymorphisms in ERCC1 and XPF gene and response to chemotherapy and overall survival of non-small cell lung cancer. International Journal of Clinical and Experimental Pathology 8(3): 3132-3137, 2015

DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clinical Lung Cancer 10(2): 118-123, 2009

DNA repair gene polymorphisms in non-small-cell lung cancer patients treated with first-line platinum-containing chemotherapy. Tumori 102(4): 367-375, 2016

Use a survival model to correlate single-nucleotide polymorphisms of DNA repair genes with radiation dose-response in patients with non-small cell lung cancer. RadioTherapy and Oncology 117(1): 77-82, 2015

Role of DNA repair gene polymorphisms in the efficiency of platinum-based adjuvant chemotherapy for non-small cell lung cancer. Molecular Diagnosis and Therapy 15(3): 159-166, 2011

Excision repair cross complementation group 1 polymorphisms predict overall survival after platinum-based chemotherapy for completely resected non-small-cell lung cancer. Journal of Surgical Research 168(2): 206-212, 2011